Members of the PEA3 (ETV5, ETV4 and ETV1) and ERG (FEV, FLI1 and ERG) sub‐families can behave as oncogenes [89], with evidence of oncogenic expression in ERG and PEA3 genes occurring early on in prostate cancer development. This evidence concerns the gene ERG and prostate carcinoma.